Varicella Zoster Virus (VZV) stromal keratitis is inflammation and injury in the middle layer of the cornea (the clear front window of the eye) caused by the chickenpox/shingles virus. After a person has chickenpox, the virus usually sleeps (goes “latent”) in the trigeminal nerve ganglion—a nerve hub near the brain. Years later, the virus can wake up (reactivate) and travel along the ophthalmic branch (V1) of that nerve to the eye and forehead. This reactivation is called herpes zoster ophthalmicus (HZO). When the corneal stroma—the thick, transparent, collagen-rich middle layer—becomes inflamed due to this virus (direct infection or immune reaction to viral pieces), we call it VZV stromal keratitis.

Varicella zoster virus (VZV) stromal keratitis is a type of cornea inflammation caused by the same virus that gives chickenpox and shingles.

• The cornea is the clear, dome-shaped “window” in front of the eye that helps focus light.

• The stroma is the thick, middle layer of the cornea made of collagen fibers and water; it gives the cornea its strength and clarity.

• Keratitis means inflammation of the cornea.

• After someone has chickenpox, VZV “sleeps” (goes latent) inside the trigeminal nerve (a face nerve). Years later it can “wake up” (reactivate) and travel down the ophthalmic branch of this nerve to the eye—a disease called herpes zoster ophthalmicus (HZO).

• In stromal keratitis, the virus or the immune system’s reaction to viral leftovers causes swelling, haze, scars, or thinning inside the corneal stroma. This can blur vision and make the eye light-sensitive and painful.

• VZV can also lower corneal sensation (the cornea becomes numb), which slows healing and can lead to neurotrophic keratopathy (a cornea that does not heal well).

In short: VZV stromal keratitis is inflammation and damage inside the thick middle layer of the cornea, triggered by shingles in or around the eye. It can be infectious (active virus in the eye) or immune-mediated (the immune system reacts to viral debris), and both can harm vision if not treated.

---

How it happens

1. Latency and reactivation: After chickenpox, VZV hides in the trigeminal ganglion. Ageing, stress, or weak immunity lets it reactivate.

2. Spread to the eye: The virus travels along the ophthalmic branch to the skin of the forehead/eyelids and to the eye’s surface and inner layers.

3. Direct viral injury vs immune injury:

   • Direct injury: Active virus in the cornea can infect cells and trigger inflammation.

   • Immune injury: Even after the virus quiets down, its proteins may remain. The immune system can “over-react” to these proteins and create nummular (coin-shaped) or disciform (disc-shaped) stromal inflammation.

4. Endothelium involvement: The endothelium (the inner corneal cell layer that pumps water out) can get inflamed (endotheliitis). When the pump fails, fluid builds in the stroma (edema), making the cornea cloudy.

5. Neurotrophic effect: The virus injures the small corneal nerves. Less feeling means less blink and tear reflex → dry surface, slow healing, and risk of ulcer or melt (thinning).

6. Scarring and astigmatism: Repeated inflammation lays down scar tissue and can warp the cornea’s shape, causing irregular astigmatism and long-term blurry vision.

---

Types of VZV stromal keratitis

1. Nummular stromal keratitis (immune type):
   Small, coin-shaped, hazy spots under the corneal surface. These are immune “footprints” reacting to viral debris. Vision may be misty; light may glare.

2. Disciform keratitis (endotheliitis-driven):
   A disc-shaped area of stromal swelling with folds in the inner corneal layer and sometimes tiny inflammatory cells on the back surface (KPs — keratic precipitates). Often very light-sensitive.

3. Interstitial stromal keratitis:
   Inflammation within the stroma without an open sore. The cornea looks hazy with patchy or diffuse clouding. If repeated, it can scar.

4. Necrotizing stromal keratitis (rare but serious):
   Aggressive inflammation with tissue breakdown. The cornea can thin (melt) and even perforate. Urgent care is needed.

5. Recurrent immune stromal keratitis:
   Repeat flares after a period of calm. Each flare increases the risk of scarring and permanent blur.

6. Lipid keratopathy (secondary):
   After long-standing inflammation, cholesterol-like deposits can settle in the stroma, causing yellow-white streaks and added haze.

7. Neurotrophic stromal keratopathy (complication subtype):
   Due to nerve damage, the cornea heals poorly. The stroma becomes vulnerable to erosions, sterile ulcers, or infection.

8. Mixed epithelial-stromal disease (overlap):
   Some patients show surface lesions (epithelial “pseudodendrites”) together with deeper stromal inflammation and endotheliitis.

---

Causes, triggers, and risk factors

Here “causes” includes what starts the problem (viral reactivation), what triggers flares, and what raises risk of stromal disease or makes it worse.

1. Viral reactivation after chickenpox:
   The root cause: dormant VZV wakes up in the trigeminal nerve and travels to the eye.

2. Older age (immunosenescence):
   The immune system weakens with age, making reactivation more likely.

3. Weakened immunity (HIV, cancer, steroids, chemo):
   Less immune control → easier for VZV to flare and spread to the cornea.

4. Diabetes mellitus:
   Alters immune responses and slows healing, increasing severity and recurrence.

5. Severe physical or emotional stress:
   Stress hormones can tip the balance toward viral reactivation.

6. Recent illness or fever:
   Systemic infections can distract the immune system and trigger shingles.

7. Malnutrition or low protein states:
   Poor nutrition impairs healing and immune defense in the cornea.

8. Delayed or no antiviral treatment at shingles onset:
   Late therapy allows more viral replication and deeper eye involvement.

9. Involvement of the nose tip (Hutchinson sign):
   Suggests the nasociliary branch is affected—higher risk of corneal disease.

10. Ocular surface dryness (dry eye disease):
    A dry, unstable tear film irritates the cornea and worsens inflammation.

11. Loss of corneal sensation (neurotrophic state):
    Numb cornea blinks less, heals poorly, and inflames more easily.

12. Mechanical micro-trauma (rubbing, dusty air):
    Small repeated injuries keep the surface inflamed, inviting stromal flares.

13. Contact lens overuse or poor hygiene:
    Not a direct cause of VZV, but can aggravate surface injury and secondary infection.

14. Eyelid problems (entropion, lagophthalmos, severe blepharitis):
    Poor lid function scratches or dries the cornea; inflammation reaches the stroma.

15. Ultraviolet (sun) exposure without protection:
    UV can increase surface inflammation and discomfort during or after HZO.

16. Co-infection or secondary bacterial keratitis:
    A second infection piles on inflammation and stromal damage.

17. Atopy/allergic eye disease:
    Allergic inflammation adds to immune activity and rub-induced trauma.

18. Smoking:
    Reduces ocular surface healing and raises oxidative stress.

19. Systemic autoimmune disease (e.g., rheumatoid arthritis):
    Baseline immune activation can intensify stromal immune reactions.

20. Previous corneal surgery or scarring:
    Prior structural weakness or sutures can localize inflammation in the stroma.

---

Symptoms and patient-reported problems

1. Blurred or foggy vision:
   Stromal haze scatters light, so images look misty.

2. Light sensitivity (photophobia):
   Inflamed corneas react painfully to light.

3. Eye pain or aching:
   Inflammation and ciliary spasm produce dull or sharp pain.

4. Red eye:
   Surface blood vessels dilate with inflammation.

5. Watering/tearing:
   Reflex tearing tries to soothe the irritated surface.

6. Foreign-body sensation (gritty feeling):
   Surface roughness makes it feel like sand is in the eye.

7. Haloes and glare at night:
   Stromal swelling and scars scatter light around lamps and headlights.

8. Reduced contrast and “washed-out” colors:
   Cloudy stroma blunts fine detail and contrast.

9. Patchy vision fluctuation through the day:
   Tear film instability makes vision come and go.

10. Decreased corneal sensation (numb cornea):
    Some patients notice less pain than expected despite active disease.

11. Droopy or swollen eyelids and skin rash history:
    Shingles rash on forehead or eyelid may have preceded the eye problem.

12. Headache in the same side as the eye:
    Trigeminal nerve irritation can cause forehead pain.

13. Difficulty keeping the eye open:
    Photophobia and surface irritation force squinting.

14. Dryness or burning:
    Damaged nerves reduce tear reflex; the eye feels dry.

15. Vision not improving with glasses:
    Irregular astigmatism and scarring reduce clarity even with new lenses.

---

Diagnostic tests

A) Physical exam–based tests (bedside observations)

1. External inspection of skin and lids:
   The clinician looks for past or present shingles rash in the V1 (forehead/upper eyelid) area and Hutchinson sign (nose tip). This points strongly to eye involvement risk.

2. Conjunctival and scleral injection assessment:
   Pattern of redness (diffuse vs ciliary flush) helps grade inflammation and rule in/out deeper involvement like uveitis.

3. Anterior chamber check with bright light (cell/flare hint):
   Even without a slit-lamp, a focused beam can reveal light scatter suggesting uveitis that often accompanies stromal keratitis.

4. Pupillary reactions:
   Poor light reaction or pain with light hints at ciliary body inflammation; relative afferent defect would suggest wider neuro-ocular involvement.

B) Manual/clinical tests (simple tools and in-office maneuvers)

5. Visual acuity (distance and near):
   Baseline and follow-up clarity measurement; documents how much haze/scar affects function.

6. Slit-lamp biomicroscopy (core exam):
   The key exam: shows nummular spots, disciform edema, KPs, stromal scars, folds in Descemet’s membrane, and surface healing.

7. Fluorescein staining pattern:
   Dye reveals surface defects and tear breakup. Helps separate epithelial lesions from deeper stromal disease and checks for Seidel sign if thinning.

8. Corneal sensation testing (cotton-wisp or Cochet–Bonnet esthesiometer):
   Measures how “numb” the cornea is. Reduced sensation supports VZV-related neurotrophic risk and guides protective therapy.

9. Intraocular pressure (IOP) measurement (tonometry):
   IOP can rise with trabeculitis or steroid response during treatment. Important safety parameter.

C) Laboratory & pathological tests

10. PCR for VZV from tears/corneal scrapings:
    Detects VZV DNA. Most useful in atypical, severe, or necrotizing cases where active virus is suspected.

11. HSV vs VZV differentiation by PCR:
    Separates VZV stromal disease from herpes simplex keratitis, which can look similar but has different relapse patterns and management nuances.

12. VZV antibody tests (serum or aqueous humor antibody index):
    In selected cases, comparing antibody levels in eye fluid versus blood helps confirm intraocular VZV activity.

13. Cytology/Smear (rarely needed):
    Conjunctival or corneal surface cells may show viral changes; less sensitive than PCR but sometimes used where PCR isn’t available.

D) Electrodiagnostic / neuro-functional tests

14. Belmonte gas esthesiometry (if available):
    A refined way to measure corneal nerve function to document neurotrophic damage, explaining poor healing.

15. Pattern visual evoked potential (pVEP) (selected cases):
    If vision loss is worse than corneal haze suggests, VEP checks for optic pathway involvement from zoster-related neuritis.

16. Electroretinography (ERG) (rare, differential):
    Usually normal in isolated keratitis; used when inflammation may have spread to the retina and the picture is unclear.

E) Imaging tests

17. Anterior segment optical coherence tomography (AS-OCT):
    Cross-section “microscope” image of the cornea. Shows stromal thickness, edema layers, and healing over time; very helpful to monitor disciform disease.

18. In vivo confocal microscopy:
    Zooms into corneal layers to visualize inflammatory cells, nerve loss, and deposits—useful for understanding severity and tracking recovery.

19. Specular microscopy or endothelial cell count:
    Assesses the health of the endothelium (inner corneal pump). Damage here supports a diagnosis of endotheliitis-driven disciform keratitis.

20. Corneal topography/tomography:
    Maps corneal shape and thickness. Documents irregular astigmatism, warpage, and areas of thinning or scar that explain persistent blur.

Non-pharmacological treatments (therapies & “other”)

(What they are, purpose, mechanism—in simple language.)

1. Cool compresses to the eyelids/forehead — Purpose: ease pain/itch and swelling during acute shingles. Mechanism: vasoconstriction and reduced nerve firing reduce discomfort. Medscape

2. Strict eye rest & light protection (sunglasses, dim lighting) — Purpose: reduce photophobia and eye strain. Mechanism: lowers trigeminal stimulation from bright light.

3. Preservative-free artificial tears (frequent use) — Purpose: soothe surface irritation; dilute inflammatory mediators. Mechanism: improves tear film and flushes debris, supporting corneal healing. (Common standard care in keratitis.) Merck Manuals

4. Lubricating gel/ointment at night — Purpose: protect the cornea during sleep, especially if blinking is reduced. Mechanism: longer-lasting barrier reduces exposure-related dryness.

5. Moisture chamber goggles — Purpose: retain humidity for severe dryness. Mechanism: reduces tear evaporation and protects epithelium.

6. Eyelid taping or protective shield during sleep (short term) — Purpose: prevent exposure if eyelid closure is incomplete from pain or swelling. Mechanism: mechanical protection of the cornea.

7. Warm compresses & lid hygiene — Purpose: treat meibomian gland dysfunction that worsens dryness. Mechanism: melts oils and stabilizes tear film.

8. Punctal occlusion (temporary plugs) — Purpose: keep natural tears on the eye longer in chronic dryness after HZO. Mechanism: slows tear drainage, improving lubrication (office procedure; no medication).

9. Scleral contact lenses (when stable) — Purpose: optical rehabilitation for irregular corneal surface/scars; moisture reservoir. Mechanism: fluid-filled vault smooths the optical surface.

10. Amniotic membrane bandage (in neurotrophic epitheliopathy) — Purpose: accelerate surface healing; reduce inflammation. Mechanism: provides growth factors and anti-inflammatory signals; placed as a biologic bandage (e.g., PROKERA). PMCEyeWorld

11. Tarsorrhaphy (temporary/partial eyelid closure) — Purpose: protect a non-healing corneal defect in neurotrophic keratopathy (a known HZO complication). Mechanism: reduces exposure and shear until nerves recover. PMCLippincott Journals

12. Corneal protective habits — Purpose: avoid contact lenses/makeup during active disease; do not rub eyes. Mechanism: reduces mechanical injury and infection risk.

13. Pain self-management basics — Purpose: layered non-drug pain control. Mechanism: pacing, gentle stretching, heat/cold alternation to reduce peripheral and central sensitization (adjunct to medical analgesia). Medscape

14. Cognitive-behavioral strategies for chronic pain/PHN — Purpose: lower stress amplification of pain. Mechanism: reframing and relaxation reduce central pain amplification. Medscape

15. Good sleep hygiene — Purpose: strengthens immune function and pain tolerance. Mechanism: improves T-cell function and healing.

16. Smoking cessation — Purpose: improves ocular surface microcirculation and healing. Mechanism: reduces oxidative stress and vasoconstriction.

17. Tight glucose control (if diabetic) — Purpose: better corneal healing and infection resistance. Mechanism: reduces glycation-driven inflammation and neuropathy risk.

18. UV protection (wrap-around sunglasses/hat) — Purpose: symptom relief and prevention of photophobia and UV-triggered inflammation. Mechanism: lowers UV-induced cytokines.

19. Vaccination against shingles (Shingrix, preventive) — Purpose: reduce future reactivation risk and eye complications; recommended routine public-health measure. Mechanism: recombinant glycoprotein E vaccine boosts VZV-specific immunity; 2-dose series. CDC+2CDC+2

20. General cardiovascular risk care — Purpose: HZO is linked to a short-term higher risk of stroke; address BP, lipids, activity. Mechanism: lowers background risk while inflammation settles. (Observational data link HZO with elevated stroke risk.) PMCOxford AcademicAHA Journals

---

Drug treatments

(Exact regimens must be individualized by the treating ophthalmologist—these are common starting points from guidelines and reviews.)

1. Valacyclovir (oral antiviral) — Class: nucleoside analog. Dose/time: 1,000 mg three times daily for ~7 days in acute HZO; some patients may then switch to 1,000 mg once daily as suppressive therapy for 12 months if recurrent keratitis/iritis (per ZEDS framework). Purpose: stop viral replication; shorten illness; reduce ocular flares. Mechanism: inhibits viral DNA polymerase after phosphorylation. Side effects: headache, nausea; rare renal issues—hydrate well; dose-adjust in kidney disease. EyeWikiClinicalTrials.govEyeWorldOphthalmology Times

2. Acyclovir (oral antiviral) — Class: nucleoside analog. Dose/time: 800 mg five times daily for 7–10 days (acute); IV acyclovir (10 mg/kg q8h) for severe/immunocompromised cases. Purpose/mechanism: as above. Side effects: GI upset, renal crystalluria—hydrate; neurotoxicity if renal impairment. NCBI

3. Famciclovir (oral antiviral) — Class: nucleoside analog (prodrug of penciclovir). Dose/time: 500 mg three times daily for 7 days. Purpose: alternative to acyclovir/valacyclovir; convenient dosing. Side effects: headache, GI upset; adjust for renal function. EyeWiki

4. Prednisolone acetate 1% (topical corticosteroid) — Class: ophthalmic steroid. Dose/time: start 4–6×/day, then very slow taper over weeks; always pair with systemic antiviral coverage. Purpose: calm stromal/endothelial inflammation and anterior uveitis, prevent scarring. Mechanism: suppresses ocular cytokines and leukocyte activity. Side effects: increased intraocular pressure (IOP), cataract risk, infection reactivation—requires close follow-up. American Academy of OphthalmologyReview of Optometry

5. Difluprednate 0.05% (topical corticosteroid, potent) — Class: ophthalmic steroid. Dose/time: e.g., 4×/day then taper (specialist-guided). Purpose/mechanism: same as prednisolone but stronger; consider when inflammation is severe. Side effects: IOP spikes can be significant—tight monitoring needed. Merck ManualsEyeWorld

6. Atropine 1% or Homatropine 5% (cycloplegics) — Class: antimuscarinic drops. Dose/time: Atropine 1% once–twice daily (or homatropine TID). Purpose: pain relief from ciliary spasm; prevents posterior synechiae in uveitis. Mechanism: paralyzes ciliary muscle and dilates pupil. Side effects: light sensitivity, blurred near vision; rare systemic effects. Merck Manuals

7. Aqueous suppressants for IOP (e.g., timolol 0.5%, brimonidine 0.2%, dorzolamide 2%) — Class: beta-blocker, alpha-agonist, carbonic-anhydrase inhibitor. Dose/time: typically BID (timolol/brimonidine) or TID/BID (dorzolamide). Purpose: reduce steroid-induced or inflammatory ocular hypertension. Mechanism: lower aqueous production or increase outflow. Side effects: timolol—bronchospasm/bradycardia; brimonidine—fatigue; dorzolamide—stinging. NCBI

8. Oral prednisone (selected cases, always with antivirals) — Class: systemic corticosteroid. Dose/time: e.g., 40–60 mg daily with rapid taper over 1–2 weeks when severe inflammation/pain; ophthalmologist-directed. Purpose: reduce severe inflammatory edema and neuritis; may speed acute pain recovery (not proven to prevent PHN). Side effects: hyperglycemia, mood change, hypertension, infection risk. Medscape

9. Neuropathic pain agents for PHN (e.g., gabapentin/pregabalin, TCAs, topical lidocaine patches) — Class: anticonvulsants/antidepressants/topical anesthetic. Dose/time: titrated to effect (e.g., gabapentin often 100–300 mg at night → gradual increase). Purpose: treat nerve pain after shingles. Mechanism: dampen abnormal nerve firing. Side effects: sleepiness, dizziness, dry mouth; caution with falls in older adults. Medscape

10. Long-term low-dose valacyclovir (suppression) after HZO — Class: antiviral prophylaxis. Dose/time: 1,000 mg once daily for 12 months in patients with recurrent keratitis/iritis—ZEDS reported reduced multiple flares and benefits that persisted at 18 months in subgroup analyses; also reduced postherpetic neuralgia metrics in a randomized study. Purpose: fewer recurrences and milder disease. Mechanism: continuous suppression of viral reactivation. Side effects: as in #1. EyeWikiEyeWorldOphthalmology TimesPubMed

Timing matters: Starting oral antivirals within 72 hours of rash onset is ideal; treat later if the eye is involved or symptoms are severe. NCBIPMC

---

Dietary “molecular” supplements

(Evidence ranges from modest to limited; these do not replace antiviral/steroid therapy.)

1. Omega-3 fatty acids (EPA/DHA; fish oil) — Dose: 1–2 g/day (EPA+DHA). Function: supports tear film and ocular surface comfort. Mechanism: anti-inflammatory lipid mediators.

2. Vitamin A (within safe limits) — Dose: typically via diet or multivitamin; avoid excess. Function: epithelial health. Mechanism: supports mucin/goblet cells and corneal epithelial differentiation.

3. Vitamin D — Dose: per local guidelines (often 800–2000 IU/day). Function: general immune modulation; bone/nerve health. Mechanism: vitamin-D receptor effects reduce inflammatory cytokines.

4. Vitamin C — Dose: 250–500 mg/day dietary-first. Function: collagen support and antioxidant defense in healing tissues. Mechanism: cofactor for collagen cross-linking; scavenges free radicals.

5. Zinc — Dose: 8–11 mg/day (RDA; avoid excess). Function: immune function/epithelial repair. Mechanism: enzymatic cofactor in DNA repair and immunity.

6. Probiotics (standard CFU blends) — Dose: per label. Function: gut–immune axis support. Mechanism: shifts cytokine profiles toward tolerance.

7. Curcumin — Dose: 500–1000 mg/day (with piperine or formulated forms). Function: adjunct anti-inflammatory. Mechanism: NF-κB pathway modulation (limited ocular-specific data).

8. Alpha-lipoic acid — Dose: 300–600 mg/day. Function: neuropathic symptom support. Mechanism: antioxidant effects on nerve metabolism.

9. B-complex (B1/B6/B12) — Dose: per label. Function: supports nerve recovery. Mechanism: coenzymes in neuronal repair.

10. L-carnitine or acetyl-L-carnitine — Dose: 500–1000 mg/day. Function: may aid neuropathic discomfort/energy metabolism. Mechanism: mitochondrial fatty-acid transport (evidence modest).

Always confirm supplement safety with your clinician (drug interactions, pregnancy, kidney disease, anticoagulants, etc.).

 Immunity/regenerative/stem-cell-type

There are no approved “stem-cell drugs” for VZV stromal keratitis. What clinicians actually use in refractory cases are adjunct immunomodulators or biologic supports—evidence is limited and strictly specialist-directed:

1. Long-term antiviral suppression (valacyclovir 1 g daily, 12 mo) — discussed above; lowers flare burden in selected patients post-HZO. EyeWikiEyeWorld

2. Topical calcineurin inhibitors (e.g., cyclosporine/lifitegrast off-label) — sometimes used to reduce steroid dependence for surface inflammation; evidence extrapolated from dry eye/HSV literature; requires monitoring.

3. Systemic immunomodulator (e.g., low-dose methotrexate) in recalcitrant keratouveitis — rare, last-line, case-series level; used with antivirals to avoid viral reactivation. Lippincott Journals

4. Autologous serum tears — biologic tear substitute rich in growth factors for neurotrophic epitheliopathy. Mechanism: supports epithelial healing (specialist compounded).

5. Amniotic membrane (biologic scaffold) — promotes regeneration of the corneal surface in non-healing defects after HZO. PMC

6. Shingrix vaccination (preventive immune “booster”) — not a treatment for active keratitis, but strongly recommended to prevent future shingles and reduce severe complications; 2-dose series for adults ≥50, and for immunocompromised adults ≥19. CDC+1

---

Surgeries

1. Amniotic membrane transplantation (AMT) — Procedure: a thin biologic membrane is placed on the cornea (suture or ring device) to encourage healing. Why: non-healing epithelial defects/neurotrophic keratopathy after HZO. Evidence: improves epithelialization and reduces inflammation. PMC

2. Temporary/partial tarsorrhaphy — Procedure: partially sewing the eyelids together to protect the cornea. Why: persistent exposure or non-healing defects when drops/AMT are insufficient. Lippincott Journals

3. Conjunctival flap (rare) — Procedure: moving vascular conjunctiva over a non-healing corneal ulcer. Why: provide blood supply and protection in severe, non-responsive cases.

4. Penetrating keratoplasty (full-thickness corneal transplant) — Procedure: replace the scarred cornea once disease is quiet. Why: visually significant scarring/edema after HZO. Notes: better outcomes when the eye has been quiescent for months and IOP/uveitis are controlled. PubMed+1

5. Lamellar keratoplasty (partial-thickness) or endothelial keratoplasty (selected) — Procedure: replace only diseased layers. Why: targeted restoration when scarring is layered or endothelial failure dominates; case-level evidence exists. Lippincott Journals

---

Prevention strategies

1. Get vaccinated (Shingrix, 2 doses). Strong public-health guidance for adults ≥50 and immunocompromised ≥19. CDC+1

2. Start antivirals early at the first sign of shingles rash or eye symptoms. NCBI

3. Consider antiviral suppression (e.g., valacyclovir 1 g daily for 12 months) if you’ve had recurrent HZO keratitis/iritis—discuss with your ophthalmologist. ClinicalTrials.govEyeWorld

4. Avoid contact lenses during active disease and until the surface is stable.

5. Protect the ocular surface (tears, gels, moisture shields).

6. Control IOP and taper steroids very slowly under supervision to prevent rebound. Review of Optometry

7. Manage systemic risks (diabetes, smoking, sleep).

8. Sun/UV protection to reduce photophobia and inflammatory triggers.

9. Hand/skin care to avoid secondary infection of rash; don’t scratch lesions. Medscape

10. Cardiovascular risk check-in after HZO, because short-term stroke risk is higher—know your BP, lipids, and warning signs. PMCOxford Academic

---

When to see a doctor

• Any shingles rash on the forehead, eyelid, or tip/side of the nose (Hutchinson sign) with eye discomfort, light sensitivity, or blurry vision—same-day eye evaluation. EyeWiki

• Sudden vision drop, severe eye pain, new floaters, halos, or red, painful eye—urgent.

• Increasing redness/swelling despite antivirals, or worsening pain after steroid taper.

• Signs of high eye pressure (eye ache, halos, headache, nausea).

• Neurologic symptoms or stroke warning signs (face droop, arm weakness, speech trouble)—call emergency services. PMCAHA Journals

---

What to eat and what to avoid

(Supportive only; not a substitute for medicine.)

Eat more of:

1. Hydrating fluids (water, broths) – support tear film and healing.

2. Oily fish (salmon, sardines) – omega-3s for ocular surface comfort.

3. Colorful vegetables & fruits – vitamins A/C/E and carotenoids for tissue repair.

4. Leafy greens – lutein/zeaxanthin; general eye health.

5. Lean proteins – amino acids for healing (fish, poultry, legumes).

6. Nuts/seeds – healthy fats & zinc.

7. Whole grains – steady energy and micronutrients.

8. Fermented foods – gut microbiome support.

9. Dairy or fortified alternatives – vitamin D/calcium.

10. Spices like turmeric/ginger – gentle anti-inflammatory support.

Limit/avoid:

1. Excess alcohol – worsens sleep, immunity, healing.

2. Smoking/vaping – delays epithelial repair.

3. Very high sugar spikes – aggravate inflammation; harm nerve healing.

4. Ultra-processed foods high in salt/fats – fluid shifts/inflammation.

5. Eye irritants (peppery fumes, strong vapors) during flares.

6. Energy drinks/late caffeine – disrupt sleep (pain worse).

7. Dehydration – thickens tears; slows healing.

8. Supplements that clash with meds (e.g., bleeding risk on anticoagulants) without approval.

9. Contact lenses/makeup until completely cleared by your doctor.

10. Home steroid use without supervision—dangerous for IOP/infection.

---

FAQs

1) Is VZV stromal keratitis contagious?
No. The shingles rash can transmit varicella (chickenpox) to a non-immune person, but your eye inflammation itself isn’t “catching.” Keep rash covered until crusted.

2) Do I always need steroid eye drops?
For stromal keratitis or uveitis, yes—steroids are standard, with antiviral cover and careful taper to avoid rebounds and pressure spikes. American Academy of Ophthalmology

3) Why do doctors insist on starting pills fast?
Oral antivirals within 72 hours reduce complications and speed recovery; treat later if the eye is involved. NCBI

4) My doctor kept me on a tiny dose of valacyclovir for months—why?
To reduce flares of keratitis/iritis after HZO. ZEDS data support 1 g daily for 12 months in selected patients. ClinicalTrials.govEyeWorld

5) Are steroid drops dangerous?
They’re essential here but must be monitored (IOP rise, cataract, infection risk). Taper very slowly as advised. Review of Optometry

6) I still have nerve pain after the rash—what helps?
Neuropathic agents like gabapentin/pregabalin, TCAs, and topical lidocaine patches can help. Work with your clinician. Medscape

7) Can vaccination help if I already had shingles in the eye?
Yes. Shingrix is still recommended to lower the chance of future shingles and its complications. CDC

8) Is there a stroke risk after eye shingles?
Yes, studies show a higher short-term stroke risk after HZO—know warning signs and optimize cardiovascular health. PMCOxford Academic

9) Can I wear contact lenses during treatment?
Avoid until your ophthalmologist confirms the surface is stable.

10) Will I need surgery?
Usually no. Surgery (AMT, tarsorrhaphy, corneal transplant) is reserved for non-healing defects or dense scarring after the eye is quiet. PMCPubMed

11) How long does it take to recover vision?
Weeks to months depending on severity and scarring. Slow steroid tapers are common to prevent rebound.

12) Can this come back?
Yes—recurrences can occur. Suppression with valacyclovir may reduce recurrence burden in selected patients. EyeWorld

13) Are “stem cell drops” available?
No approved “stem-cell drugs” exist for this. Serum tears and amniotic membrane are the real-world biologic supports used in stubborn surface disease. PMC

14) What about oral steroids without antivirals?
Do not use systemic or topical steroids alone—always pair with antivirals in this disease. Medscape

15) What follow-up do I need?
Frequent visits at first to check IOP, corneal clarity, and response to taper; longer-term monitoring for recurrences.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 30, 2025.